 Global Targeted Protein Degradation (TPD) Therapy Drugs Market Growth 2026-2032
The global Targeted Protein Degradation (TPD) Therapy Drugs market size is predicted to grow from US$ 19801 million in 2025 to US$ 39443 million in 2032; it is expected to grow at a CAGR of 10.9% f... もっと見る
英語原文をAIを使って翻訳しています。
図表リストList of TablesTable 1. Targeted Protein Degradation (TPD) Therapy Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions) Table 2. Targeted Protein Degradation (TPD) Therapy Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions) Table 3. Major Players of PROTAC Table 4. Major Players of Molecular Glues Table 5. Major Players of Others Table 6. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales by Type (2021-2026) & (K Units) Table 7. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Type (2021-2026) Table 8. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Type (2021-2026) & ($ million) Table 9. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Type (2021-2026) Table 10. Global Targeted Protein Degradation (TPD) Therapy Drugs Sale Price by Type (2021-2026) & (US$/Unit) Table 11. Major Players of Degradation of Transcription Factors Type Table 12. Major Players of Degradation of Scaffold Proteins Type Table 13. Major Players of Others Table 14. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales by Target Protein (2021-2026) & (K Units) Table 15. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Target Protein (2021-2026) Table 16. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Target Protein (2021-2026) & ($ million) Table 17. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Target Protein (2021-2026) Table 18. Global Targeted Protein Degradation (TPD) Therapy Drugs Sale Price by Target Protein (2021-2026) & (US$/Unit) Table 19. Major Players of Oral Drugs Table 20. Major Players of Injectable Drugs Table 21. Major Players of Others Table 22. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales by Administration Route (2021-2026) & (K Units) Table 23. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Administration Route (2021-2026) Table 24. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Administration Route (2021-2026) & ($ million) Table 25. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Administration Route (2021-2026) Table 26. Global Targeted Protein Degradation (TPD) Therapy Drugs Sale Price by Administration Route (2021-2026) & (US$/Unit) Table 27. Global Targeted Protein Degradation (TPD) Therapy Drugs Sale by Application (2021-2026) & (K Units) Table 28. Global Targeted Protein Degradation (TPD) Therapy Drugs Sale Market Share by Application (2021-2026) Table 29. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Application (2021-2026) & ($ million) Table 30. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Application (2021-2026) Table 31. Global Targeted Protein Degradation (TPD) Therapy Drugs Sale Price by Application (2021-2026) & (US$/Unit) Table 32. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales by Company (2021-2026) & (K Units) Table 33. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Company (2021-2026) Table 34. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Company (2021-2026) & ($ millions) Table 35. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Company (2021-2026) Table 36. Global Targeted Protein Degradation (TPD) Therapy Drugs Sale Price by Company (2021-2026) & (US$/Unit) Table 37. Key Manufacturers Targeted Protein Degradation (TPD) Therapy Drugs Producing Area Distribution and Sales Area Table 38. Players Targeted Protein Degradation (TPD) Therapy Drugs Products Offered Table 39. Targeted Protein Degradation (TPD) Therapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) Table 40. New Products and Potential Entrants Table 41. Market M&A Activity & Strategy Table 42. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales by Geographic Region (2021-2026) & (K Units) Table 43. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share Geographic Region (2021-2026) Table 44. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Geographic Region (2021-2026) & ($ millions) Table 45. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Geographic Region (2021-2026) Table 46. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales by Country/Region (2021-2026) & (K Units) Table 47. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Country/Region (2021-2026) Table 48. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Country/Region (2021-2026) & ($ millions) Table 49. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Country/Region (2021-2026) Table 50. Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales by Country (2021-2026) & (K Units) Table 51. Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Country (2021-2026) Table 52. Americas Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Country (2021-2026) & ($ millions) Table 53. Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales by Type (2021-2026) & (K Units) Table 54. Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales by Application (2021-2026) & (K Units) Table 55. APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales by Region (2021-2026) & (K Units) Table 56. APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Region (2021-2026) Table 57. APAC Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Region (2021-2026) & ($ millions) Table 58. APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales by Type (2021-2026) & (K Units) Table 59. APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales by Application (2021-2026) & (K Units) Table 60. Europe Targeted Protein Degradation (TPD) Therapy Drugs Sales by Country (2021-2026) & (K Units) Table 61. Europe Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Country (2021-2026) & ($ millions) Table 62. Europe Targeted Protein Degradation (TPD) Therapy Drugs Sales by Type (2021-2026) & (K Units) Table 63. Europe Targeted Protein Degradation (TPD) Therapy Drugs Sales by Application (2021-2026) & (K Units) Table 64. Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Sales by Country (2021-2026) & (K Units) Table 65. Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Country (2021-2026) Table 66. Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Sales by Type (2021-2026) & (K Units) Table 67. Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Sales by Application (2021-2026) & (K Units) Table 68. Key Market Drivers & Growth Opportunities of Targeted Protein Degradation (TPD) Therapy Drugs Table 69. Key Market Challenges & Risks of Targeted Protein Degradation (TPD) Therapy Drugs Table 70. Key Industry Trends of Targeted Protein Degradation (TPD) Therapy Drugs Table 71. Targeted Protein Degradation (TPD) Therapy Drugs Raw Material Table 72. Key Suppliers of Raw Materials Table 73. Targeted Protein Degradation (TPD) Therapy Drugs Distributors List Table 74. Targeted Protein Degradation (TPD) Therapy Drugs Customer List Table 75. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Forecast by Region (2027-2032) & (K Units) Table 76. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Forecast by Region (2027-2032) & ($ millions) Table 77. Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 78. Americas Targeted Protein Degradation (TPD) Therapy Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions) Table 79. APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales Forecast by Region (2027-2032) & (K Units) Table 80. APAC Targeted Protein Degradation (TPD) Therapy Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions) Table 81. Europe Targeted Protein Degradation (TPD) Therapy Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 82. Europe Targeted Protein Degradation (TPD) Therapy Drugs Revenue Forecast by Country (2027-2032) & ($ millions) Table 83. Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 84. Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Revenue Forecast by Country (2027-2032) & ($ millions) Table 85. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Forecast by Type (2027-2032) & (K Units) Table 86. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Forecast by Type (2027-2032) & ($ millions) Table 87. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Forecast by Application (2027-2032) & (K Units) Table 88. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Forecast by Application (2027-2032) & ($ millions) Table 89. BMS Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 90. BMS Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 91. BMS Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. BMS Main Business Table 93. BMS Latest Developments Table 94. Arvinas Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 95. Arvinas Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 96. Arvinas Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Arvinas Main Business Table 98. Arvinas Latest Developments Table 99. Kymera Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 100. Kymera Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 101. Kymera Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Kymera Main Business Table 103. Kymera Latest Developments Table 104. Nurix Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 105. Nurix Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 106. Nurix Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Nurix Main Business Table 108. Nurix Latest Developments Table 109. C4 Therapeutics Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 110. C4 Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 111. C4 Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. C4 Therapeutics Main Business Table 113. C4 Therapeutics Latest Developments Table 114. Cullgen Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 115. Cullgen Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 116. Cullgen Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Cullgen Main Business Table 118. Cullgen Latest Developments Table 119. Kintor Pharma Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 120. Kintor Pharma Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 121. Kintor Pharma Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Kintor Pharma Main Business Table 123. Kintor Pharma Latest Developments Table 124. Prelude Therapeutics Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 125. Prelude Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 126. Prelude Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Prelude Therapeutics Main Business Table 128. Prelude Therapeutics Latest Developments Table 129. AbbVie Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 130. AbbVie Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 131. AbbVie Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. AbbVie Main Business Table 133. AbbVie Latest Developments Table 134. Accutar Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 135. Accutar Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 136. Accutar Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Accutar Main Business Table 138. Accutar Latest Developments Table 139. AnHorn Medicines Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 140. AnHorn Medicines Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 141. AnHorn Medicines Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. AnHorn Medicines Main Business Table 143. AnHorn Medicines Latest Developments Table 144. Astellas Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 145. Astellas Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 146. Astellas Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Astellas Main Business Table 148. Astellas Latest Developments Table 149. Auron Therapeutics Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 150. Auron Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 151. Auron Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Auron Therapeutics Main Business Table 153. Auron Therapeutics Latest Developments Table 154. Axter Therapeutics Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 155. Axter Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 156. Axter Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Axter Therapeutics Main Business Table 158. Axter Therapeutics Latest Developments Table 159. Biotheryx Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 160. Biotheryx Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 161. Biotheryx Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Biotheryx Main Business Table 163. Biotheryx Latest Developments Table 164. Dialectic Therapeutics Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 165. Dialectic Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 166. Dialectic Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Dialectic Therapeutics Main Business Table 168. Dialectic Therapeutics Latest Developments Table 169. Hinova Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 170. Hinova Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 171. Hinova Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 172. Hinova Main Business Table 173. Hinova Latest Developments Table 174. Hinova Pharmaceuticals Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 175. Hinova Pharmaceuticals Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 176. Hinova Pharmaceuticals Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 177. Hinova Pharmaceuticals Main Business Table 178. Hinova Pharmaceuticals Latest Developments Table 179. Haisco Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 180. Haisco Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 181. Haisco Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 182. Haisco Main Business Table 183. Haisco Latest Developments Table 184. Leadingtac Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 185. Leadingtac Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 186. Leadingtac Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 187. Leadingtac Main Business Table 188. Leadingtac Latest Developments Table 189. Mitsubishi Tanabe Pharma America Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 190. Mitsubishi Tanabe Pharma America Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 191. Mitsubishi Tanabe Pharma America Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 192. Mitsubishi Tanabe Pharma America Main Business Table 193. Mitsubishi Tanabe Pharma America Latest Developments Table 194. NiKang Therapeutics Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 195. NiKang Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 196. NiKang Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 197. NiKang Therapeutics Main Business Table 198. NiKang Therapeutics Latest Developments Table 199. Ubix Therapeutics Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 200. Ubix Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 201. Ubix Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 202. Ubix Therapeutics Main Business Table 203. Ubix Therapeutics Latest Developments Table 204. Foghorn Therapeutics Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 205. Foghorn Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 206. Foghorn Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 207. Foghorn Therapeutics Main Business Table 208. Foghorn Therapeutics Latest Developments Table 209. Beigene, Ltd. Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 210. Beigene, Ltd. Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 211. Beigene, Ltd. Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 212. Beigene, Ltd. Main Business Table 213. Beigene, Ltd. Latest Developments Table 214. Jiangsu Hengrui Medicine Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 215. Jiangsu Hengrui Medicine Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 216. Jiangsu Hengrui Medicine Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 217. Jiangsu Hengrui Medicine Main Business Table 218. Jiangsu Hengrui Medicine Latest Developments Table 219. Qilu Pharmaceutical Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 220. Qilu Pharmaceutical Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 221. Qilu Pharmaceutical Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 222. Qilu Pharmaceutical Main Business Table 223. Qilu Pharmaceutical Latest Developments Table 224. Simcere Pharma Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 225. Simcere Pharma Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 226. Simcere Pharma Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 227. Simcere Pharma Main Business Table 228. Simcere Pharma Latest Developments Table 229. Chia Tai Tianqing Pharmaceutical Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 230. Chia Tai Tianqing Pharmaceutical Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 231. Chia Tai Tianqing Pharmaceutical Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 232. Chia Tai Tianqing Pharmaceutical Main Business Table 233. Chia Tai Tianqing Pharmaceutical Latest Developments List of Figures Figure 1. Picture of Targeted Protein Degradation (TPD) Therapy Drugs Figure 2. Targeted Protein Degradation (TPD) Therapy Drugs Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Growth Rate 2021-2032 (K Units) Figure 7. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth Rate 2021-2032 ($ millions) Figure 8. Targeted Protein Degradation (TPD) Therapy Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions) Figure 9. Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Country/Region (2025) Figure 10. Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Country/Region (2021, 2025 & 2032) Figure 11. Product Picture of PROTAC Figure 12. Product Picture of Molecular Glues Figure 13. Product Picture of Others Figure 14. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Type in 2026 Figure 15. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Type (2021-2026) Figure 16. Product Picture of Degradation of Transcription Factors Type Figure 17. Product Picture of Degradation of Scaffold Proteins Type Figure 18. Product Picture of Others Figure 19. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Target Protein in 2026 Figure 20. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Target Protein (2021-2026) Figure 21. Product Picture of Oral Drugs Figure 22. Product Picture of Injectable Drugs Figure 23. Product Picture of Others Figure 24. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Administration Route in 2026 Figure 25. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Administration Route (2021-2026) Figure 26. Targeted Protein Degradation (TPD) Therapy Drugs Consumed in Cancer Figure 27. Global Targeted Protein Degradation (TPD) Therapy Drugs Market: Cancer (2021-2026) & (K Units) Figure 28. Targeted Protein Degradation (TPD) Therapy Drugs Consumed in Immune Diseases Figure 29. Global Targeted Protein Degradation (TPD) Therapy Drugs Market: Immune Diseases (2021-2026) & (K Units) Figure 30. Targeted Protein Degradation (TPD) Therapy Drugs Consumed in Others Figure 31. Global Targeted Protein Degradation (TPD) Therapy Drugs Market: Others (2021-2026) & (K Units) Figure 32. Global Targeted Protein Degradation (TPD) Therapy Drugs Sale Market Share by Application (2025) Figure 33. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Application in 2026 Figure 34. Targeted Protein Degradation (TPD) Therapy Drugs Sales by Company in 2026 (K Units) Figure 35. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Company in 2026 Figure 36. Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Company in 2026 ($ millions) Figure 37. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Company in 2026 Figure 38. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Geographic Region (2021-2026) Figure 39. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Geographic Region in 2026 Figure 40. Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales 2021-2026 (K Units) Figure 41. Americas Targeted Protein Degradation (TPD) Therapy Drugs Revenue 2021-2026 ($ millions) Figure 42. APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales 2021-2026 (K Units) Figure 43. APAC Targeted Protein Degradation (TPD) Therapy Drugs Revenue 2021-2026 ($ millions) Figure 44. Europe Targeted Protein Degradation (TPD) Therapy Drugs Sales 2021-2026 (K Units) Figure 45. Europe Targeted Protein Degradation (TPD) Therapy Drugs Revenue 2021-2026 ($ millions) Figure 46. Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Sales 2021-2026 (K Units) Figure 47. Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Revenue 2021-2026 ($ millions) Figure 48. Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Country in 2026 Figure 49. Americas Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Country (2021-2026) Figure 50. Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Type (2021-2026) Figure 51. Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Application (2021-2026) Figure 52. United States Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 53. Canada Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 54. Mexico Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 55. Brazil Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 56. APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Region in 2026 Figure 57. APAC Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Region (2021-2026) Figure 58. APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Type (2021-2026) Figure 59. APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Application (2021-2026) Figure 60. China Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 61. Japan Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 62. South Korea Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 63. Southeast Asia Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 64. India Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 65. Australia Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 66. China Taiwan Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 67. Europe Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Country in 2026 Figure 68. Europe Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Country (2021-2026)
SummaryThe global Targeted Protein Degradation (TPD) Therapy Drugs market size is predicted to grow from US$ 19801 million in 2025 to US$ 39443 million in 2032; it is expected to grow at a CAGR of 10.9% from 2026 to 2032.In 2025, global Targeted protein degradation (TPD) Therapy Drugs reached approximately 1338 K Units, with an average global market price of around 121.33 USD per Unit. Targeted Protein Degradation (TPD) therapy drugs are a class of innovative medicines that treat disease by selectively eliminating specific proteins inside cells, rather than merely inhibiting their activity. These therapies work by harnessing the cell’s natural protein disposal systems, most commonly the ubiquitin–proteasome pathway or, in some cases, lysosomal degradation pathways, to remove disease-causing or disease-driving proteins. Targeted protein degradation (TPD) Therapy Drugs are an emerging class of small-molecule medicines designed to treat disease by selectively removing, rather than merely inhibiting, specific proteins through the cell’s own ubiquitin–proteasome degradation system. This “event-driven” mechanism addresses several persistent pain points in drug development: it can overcome situations where conventional inhibitors lose effectiveness due to resistance mutations, it can achieve deeper and more sustained pathway control by eliminating the target protein altogether, and it opens new possibilities for proteins that are difficult to modulate with classic active-site binding strategies. Industry momentum is being fueled by rapid advances in target biology and structural design, growing confidence in the translational value of targeted protein degradation, and strong demand in areas such as oncology and immune-mediated diseases where durable responses and differentiation matter most. Looking ahead, market potential is supported by an expanding pipeline of degrader programs, improving chemistry and drug-like properties that enable more practical dosing and broader tissue reach, and the likelihood that successful Targeted protein degradation (TPD) Therapy Drugs will complement—rather than simply replace—existing targeted therapies, creating a meaningful new layer of precision medicine built around controlling protein levels instead of just protein activity. The upstream raw materials for Targeted Protein Degradation (TPD) Therapy Drugs mainly include target protein (POI) ligands, E3 ligase ligands, excipients, etc. Typical suppliers include Bio-Techne, Merck, Sigma-Aldrich, Enamine, etc. The downstream applications are mainly in the treatment of cancer, immune diseases, etc. The production capacity of Targeted protein degradation (TPD) Therapy Drugs varies significantly depending on the technology route, production stage, and commercialization progress. The gross profit margin of Targeted protein degradation (TPD) Therapy Drugs is usually between 70-80%. United States market for Targeted Protein Degradation (TPD) Therapy Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. China market for Targeted Protein Degradation (TPD) Therapy Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. Europe market for Targeted Protein Degradation (TPD) Therapy Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. Global key Targeted Protein Degradation (TPD) Therapy Drugs players cover BMS, Arvinas, Kymera, Nurix, C4 Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025. Report Scope LP Information, Inc. (LPI) ' newest research report, the “Targeted Protein Degradation (TPD) Therapy Drugs Industry Forecast” looks at past sales and reviews total world Targeted Protein Degradation (TPD) Therapy Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Targeted Protein Degradation (TPD) Therapy Drugs sales for 2026 through 2032. With Targeted Protein Degradation (TPD) Therapy Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Protein Degradation (TPD) Therapy Drugs industry. This Insight Report provides a comprehensive analysis of the global Targeted Protein Degradation (TPD) Therapy Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeted Protein Degradation (TPD) Therapy Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Protein Degradation (TPD) Therapy Drugs market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Protein Degradation (TPD) Therapy Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Protein Degradation (TPD) Therapy Drugs. This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Protein Degradation (TPD) Therapy Drugs market by product type, application, key manufacturers and key regions and countries. Market Segmentation Segmentation by Type: PROTAC Molecular Glues Others Segmentation by Target Protein: Degradation of Transcription Factors Type Degradation of Scaffold Proteins Type Others Segmentation by Administration Route: Oral Drugs Injectable Drugs Others Segmentation by Application: Cancer Immune Diseases Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration. BMS Arvinas Kymera Nurix C4 Therapeutics Cullgen Kintor Pharma Prelude Therapeutics AbbVie Accutar AnHorn Medicines Astellas Auron Therapeutics Axter Therapeutics Biotheryx Dialectic Therapeutics Hinova Hinova Pharmaceuticals Haisco Leadingtac Mitsubishi Tanabe Pharma America NiKang Therapeutics Ubix Therapeutics Foghorn Therapeutics Beigene, Ltd. Jiangsu Hengrui Medicine Qilu Pharmaceutical Simcere Pharma Chia Tai Tianqing Pharmaceutical Key Questions Addressed in this Report What is the 10-year outlook for the global Targeted Protein Degradation (TPD) Therapy Drugs market? What factors are driving Targeted Protein Degradation (TPD) Therapy Drugs market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Targeted Protein Degradation (TPD) Therapy Drugs market opportunities vary by end market size? How does Targeted Protein Degradation (TPD) Therapy Drugs break out by Type, by Application? Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Targeted Protein Degradation (TPD) Therapy Drugs Annual Sales 2021-2032 2.1.2 World Current & Future Analysis for Targeted Protein Degradation (TPD) Therapy Drugs by Geographic Region, 2021, 2025 & 2032 2.1.3 World Current & Future Analysis for Targeted Protein Degradation (TPD) Therapy Drugs by Country/Region, 2021, 2025 & 2032 2.2 Targeted Protein Degradation (TPD) Therapy Drugs Segment by Type 2.2.1 PROTAC 2.2.2 Molecular Glues 2.2.3 Others 2.2.4 Targeted Protein Degradation (TPD) Therapy Drugs Sales by Type 2.2.4.1 Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Type (2021-2026) 2.2.4.2 Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue and Market Share by Type (2021-2026) 2.2.4.3 Global Targeted Protein Degradation (TPD) Therapy Drugs Sale Price by Type (2021-2026) 2.3 Targeted Protein Degradation (TPD) Therapy Drugs Segment by Target Protein 2.3.1 Degradation of Transcription Factors Type 2.3.2 Degradation of Scaffold Proteins Type 2.3.3 Others 2.3.4 Targeted Protein Degradation (TPD) Therapy Drugs Sales by Target Protein 2.3.4.1 Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Target Protein (2021-2026) 2.3.4.2 Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue and Market Share by Target Protein (2021-2026) 2.3.4.3 Global Targeted Protein Degradation (TPD) Therapy Drugs Sale Price by Target Protein (2021-2026) 2.4 Targeted Protein Degradation (TPD) Therapy Drugs Segment by Administration Route 2.4.1 Oral Drugs 2.4.2 Injectable Drugs 2.4.3 Others 2.4.4 Targeted Protein Degradation (TPD) Therapy Drugs Sales by Administration Route 2.4.4.1 Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Administration Route (2021-2026) 2.4.4.2 Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue and Market Share by Administration Route (2021-2026) 2.4.4.3 Global Targeted Protein Degradation (TPD) Therapy Drugs Sale Price by Administration Route (2021-2026) 2.5 Targeted Protein Degradation (TPD) Therapy Drugs Segment by Application 2.5.1 Cancer 2.5.2 Immune Diseases 2.5.3 Others 2.5.4 Targeted Protein Degradation (TPD) Therapy Drugs Sales by Application 2.5.4.1 Global Targeted Protein Degradation (TPD) Therapy Drugs Sale Market Share by Application (2021-2026) 2.5.4.2 Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue and Market Share by Application (2021-2026) 2.5.4.3 Global Targeted Protein Degradation (TPD) Therapy Drugs Sale Price by Application (2021-2026) 3 Global by Company 3.1 Global Targeted Protein Degradation (TPD) Therapy Drugs Breakdown Data by Company 3.1.1 Global Targeted Protein Degradation (TPD) Therapy Drugs Annual Sales by Company (2021-2026) 3.1.2 Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Company (2021-2026) 3.2 Global Targeted Protein Degradation (TPD) Therapy Drugs Annual Revenue by Company (2021-2026) 3.2.1 Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Company (2021-2026) 3.2.2 Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Company (2021-2026) 3.3 Global Targeted Protein Degradation (TPD) Therapy Drugs Sale Price by Company 3.4 Key Manufacturers Targeted Protein Degradation (TPD) Therapy Drugs Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Targeted Protein Degradation (TPD) Therapy Drugs Product Location Distribution 3.4.2 Players Targeted Protein Degradation (TPD) Therapy Drugs Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Targeted Protein Degradation (TPD) Therapy Drugs by Geographic Region 4.1 World Historic Targeted Protein Degradation (TPD) Therapy Drugs Market Size by Geographic Region (2021-2026) 4.1.1 Global Targeted Protein Degradation (TPD) Therapy Drugs Annual Sales by Geographic Region (2021-2026) 4.1.2 Global Targeted Protein Degradation (TPD) Therapy Drugs Annual Revenue by Geographic Region (2021-2026) 4.2 World Historic Targeted Protein Degradation (TPD) Therapy Drugs Market Size by Country/Region (2021-2026) 4.2.1 Global Targeted Protein Degradation (TPD) Therapy Drugs Annual Sales by Country/Region (2021-2026) 4.2.2 Global Targeted Protein Degradation (TPD) Therapy Drugs Annual Revenue by Country/Region (2021-2026) 4.3 Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales Growth 4.4 APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales Growth 4.5 Europe Targeted Protein Degradation (TPD) Therapy Drugs Sales Growth 4.6 Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Sales Growth 5 Americas 5.1 Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales by Country 5.1.1 Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales by Country (2021-2026) 5.1.2 Americas Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Country (2021-2026) 5.2 Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales by Type (2021-2026) 5.3 Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales by Application (2021-2026) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales by Region 6.1.1 APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales by Region (2021-2026) 6.1.2 APAC Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Region (2021-2026) 6.2 APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales by Type (2021-2026) 6.3 APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales by Application (2021-2026) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Targeted Protein Degradation (TPD) Therapy Drugs by Country 7.1.1 Europe Targeted Protein Degradation (TPD) Therapy Drugs Sales by Country (2021-2026) 7.1.2 Europe Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Country (2021-2026) 7.2 Europe Targeted Protein Degradation (TPD) Therapy Drugs Sales by Type (2021-2026) 7.3 Europe Targeted Protein Degradation (TPD) Therapy Drugs Sales by Application (2021-2026) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs by Country 8.1.1 Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Sales by Country (2021-2026) 8.1.2 Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Country (2021-2026) 8.2 Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Sales by Type (2021-2026) 8.3 Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Sales by Application (2021-2026) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Targeted Protein Degradation (TPD) Therapy Drugs 10.3 Manufacturing Process Analysis of Targeted Protein Degradation (TPD) Therapy Drugs 10.4 Industry Chain Structure of Targeted Protein Degradation (TPD) Therapy Drugs 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Targeted Protein Degradation (TPD) Therapy Drugs Distributors 11.3 Targeted Protein Degradation (TPD) Therapy Drugs Customer 12 World Forecast Review for Targeted Protein Degradation (TPD) Therapy Drugs by Geographic Region 12.1 Global Targeted Protein Degradation (TPD) Therapy Drugs Market Size Forecast by Region 12.1.1 Global Targeted Protein Degradation (TPD) Therapy Drugs Forecast by Region (2027-2032) 12.1.2 Global Targeted Protein Degradation (TPD) Therapy Drugs Annual Revenue Forecast by Region (2027-2032) 12.2 Americas Forecast by Country (2027-2032) 12.3 APAC Forecast by Region (2027-2032) 12.4 Europe Forecast by Country (2027-2032) 12.5 Middle East & Africa Forecast by Country (2027-2032) 12.6 Global Targeted Protein Degradation (TPD) Therapy Drugs Forecast by Type (2027-2032) 12.7 Global Targeted Protein Degradation (TPD) Therapy Drugs Forecast by Application (2027-2032) 13 Key Players Analysis 13.1 BMS 13.1.1 BMS Company Information 13.1.2 BMS Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.1.3 BMS Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.1.4 BMS Main Business Overview 13.1.5 BMS Latest Developments 13.2 Arvinas 13.2.1 Arvinas Company Information 13.2.2 Arvinas Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.2.3 Arvinas Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.2.4 Arvinas Main Business Overview 13.2.5 Arvinas Latest Developments 13.3 Kymera 13.3.1 Kymera Company Information 13.3.2 Kymera Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.3.3 Kymera Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.3.4 Kymera Main Business Overview 13.3.5 Kymera Latest Developments 13.4 Nurix 13.4.1 Nurix Company Information 13.4.2 Nurix Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.4.3 Nurix Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.4.4 Nurix Main Business Overview 13.4.5 Nurix Latest Developments 13.5 C4 Therapeutics 13.5.1 C4 Therapeutics Company Information 13.5.2 C4 Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.5.3 C4 Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.5.4 C4 Therapeutics Main Business Overview 13.5.5 C4 Therapeutics Latest Developments 13.6 Cullgen 13.6.1 Cullgen Company Information 13.6.2 Cullgen Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.6.3 Cullgen Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.6.4 Cullgen Main Business Overview 13.6.5 Cullgen Latest Developments 13.7 Kintor Pharma 13.7.1 Kintor Pharma Company Information 13.7.2 Kintor Pharma Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.7.3 Kintor Pharma Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.7.4 Kintor Pharma Main Business Overview 13.7.5 Kintor Pharma Latest Developments 13.8 Prelude Therapeutics 13.8.1 Prelude Therapeutics Company Information 13.8.2 Prelude Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.8.3 Prelude Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.8.4 Prelude Therapeutics Main Business Overview 13.8.5 Prelude Therapeutics Latest Developments 13.9 AbbVie 13.9.1 AbbVie Company Information 13.9.2 AbbVie Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.9.3 AbbVie Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.9.4 AbbVie Main Business Overview 13.9.5 AbbVie Latest Developments 13.10 Accutar 13.10.1 Accutar Company Information 13.10.2 Accutar Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.10.3 Accutar Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.10.4 Accutar Main Business Overview 13.10.5 Accutar Latest Developments 13.11 AnHorn Medicines 13.11.1 AnHorn Medicines Company Information 13.11.2 AnHorn Medicines Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.11.3 AnHorn Medicines Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.11.4 AnHorn Medicines Main Business Overview 13.11.5 AnHorn Medicines Latest Developments 13.12 Astellas 13.12.1 Astellas Company Information 13.12.2 Astellas Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.12.3 Astellas Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.12.4 Astellas Main Business Overview 13.12.5 Astellas Latest Developments 13.13 Auron Therapeutics 13.13.1 Auron Therapeutics Company Information 13.13.2 Auron Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.13.3 Auron Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.13.4 Auron Therapeutics Main Business Overview 13.13.5 Auron Therapeutics Latest Developments 13.14 Axter Therapeutics 13.14.1 Axter Therapeutics Company Information 13.14.2 Axter Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.14.3 Axter Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.14.4 Axter Therapeutics Main Business Overview 13.14.5 Axter Therapeutics Latest Developments 13.15 Biotheryx 13.15.1 Biotheryx Company Information 13.15.2 Biotheryx Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.15.3 Biotheryx Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.15.4 Biotheryx Main Business Overview 13.15.5 Biotheryx Latest Developments 13.16 Dialectic Therapeutics 13.16.1 Dialectic Therapeutics Company Information 13.16.2 Dialectic Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.16.3 Dialectic Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.16.4 Dialectic Therapeutics Main Business Overview 13.16.5 Dialectic Therapeutics Latest Developments 13.17 Hinova 13.17.1 Hinova Company Information 13.17.2 Hinova Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.17.3 Hinova Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.17.4 Hinova Main Business Overview 13.17.5 Hinova Latest Developments 13.18 Hinova Pharmaceuticals 13.18.1 Hinova Pharmaceuticals Company Information 13.18.2 Hinova Pharmaceuticals Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.18.3 Hinova Pharmaceuticals Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.18.4 Hinova Pharmaceuticals Main Business Overview 13.18.5 Hinova Pharmaceuticals Latest Developments 13.19 Haisco 13.19.1 Haisco Company Information 13.19.2 Haisco Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.19.3 Haisco Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.19.4 Haisco Main Business Overview 13.19.5 Haisco Latest Developments 13.20 Leadingtac 13.20.1 Leadingtac Company Information 13.20.2 Leadingtac Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.20.3 Leadingtac Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.20.4 Leadingtac Main Business Overview 13.20.5 Leadingtac Latest Developments 13.21 Mitsubishi Tanabe Pharma America 13.21.1 Mitsubishi Tanabe Pharma America Company Information 13.21.2 Mitsubishi Tanabe Pharma America Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.21.3 Mitsubishi Tanabe Pharma America Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.21.4 Mitsubishi Tanabe Pharma America Main Business Overview 13.21.5 Mitsubishi Tanabe Pharma America Latest Developments 13.22 NiKang Therapeutics 13.22.1 NiKang Therapeutics Company Information 13.22.2 NiKang Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.22.3 NiKang Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.22.4 NiKang Therapeutics Main Business Overview 13.22.5 NiKang Therapeutics Latest Developments 13.23 Ubix Therapeutics 13.23.1 Ubix Therapeutics Company Information 13.23.2 Ubix Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.23.3 Ubix Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.23.4 Ubix Therapeutics Main Business Overview 13.23.5 Ubix Therapeutics Latest Developments 13.24 Foghorn Therapeutics 13.24.1 Foghorn Therapeutics Company Information 13.24.2 Foghorn Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.24.3 Foghorn Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.24.4 Foghorn Therapeutics Main Business Overview 13.24.5 Foghorn Therapeutics Latest Developments 13.25 Beigene, Ltd. 13.25.1 Beigene, Ltd. Company Information 13.25.2 Beigene, Ltd. Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.25.3 Beigene, Ltd. Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.25.4 Beigene, Ltd. Main Business Overview 13.25.5 Beigene, Ltd. Latest Developments 13.26 Jiangsu Hengrui Medicine 13.26.1 Jiangsu Hengrui Medicine Company Information 13.26.2 Jiangsu Hengrui Medicine Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.26.3 Jiangsu Hengrui Medicine Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.26.4 Jiangsu Hengrui Medicine Main Business Overview 13.26.5 Jiangsu Hengrui Medicine Latest Developments 13.27 Qilu Pharmaceutical 13.27.1 Qilu Pharmaceutical Company Information 13.27.2 Qilu Pharmaceutical Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.27.3 Qilu Pharmaceutical Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.27.4 Qilu Pharmaceutical Main Business Overview 13.27.5 Qilu Pharmaceutical Latest Developments 13.28 Simcere Pharma 13.28.1 Simcere Pharma Company Information 13.28.2 Simcere Pharma Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.28.3 Simcere Pharma Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.28.4 Simcere Pharma Main Business Overview 13.28.5 Simcere Pharma Latest Developments 13.29 Chia Tai Tianqing Pharmaceutical 13.29.1 Chia Tai Tianqing Pharmaceutical Company Information 13.29.2 Chia Tai Tianqing Pharmaceutical Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications 13.29.3 Chia Tai Tianqing Pharmaceutical Targeted Protein Degradation (TPD) Therapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.29.4 Chia Tai Tianqing Pharmaceutical Main Business Overview 13.29.5 Chia Tai Tianqing Pharmaceutical Latest Developments 14 Research Findings and Conclusion List of Tables/GraphsList of TablesTable 1. Targeted Protein Degradation (TPD) Therapy Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions) Table 2. Targeted Protein Degradation (TPD) Therapy Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions) Table 3. Major Players of PROTAC Table 4. Major Players of Molecular Glues Table 5. Major Players of Others Table 6. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales by Type (2021-2026) & (K Units) Table 7. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Type (2021-2026) Table 8. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Type (2021-2026) & ($ million) Table 9. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Type (2021-2026) Table 10. Global Targeted Protein Degradation (TPD) Therapy Drugs Sale Price by Type (2021-2026) & (US$/Unit) Table 11. Major Players of Degradation of Transcription Factors Type Table 12. Major Players of Degradation of Scaffold Proteins Type Table 13. Major Players of Others Table 14. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales by Target Protein (2021-2026) & (K Units) Table 15. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Target Protein (2021-2026) Table 16. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Target Protein (2021-2026) & ($ million) Table 17. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Target Protein (2021-2026) Table 18. Global Targeted Protein Degradation (TPD) Therapy Drugs Sale Price by Target Protein (2021-2026) & (US$/Unit) Table 19. Major Players of Oral Drugs Table 20. Major Players of Injectable Drugs Table 21. Major Players of Others Table 22. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales by Administration Route (2021-2026) & (K Units) Table 23. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Administration Route (2021-2026) Table 24. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Administration Route (2021-2026) & ($ million) Table 25. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Administration Route (2021-2026) Table 26. Global Targeted Protein Degradation (TPD) Therapy Drugs Sale Price by Administration Route (2021-2026) & (US$/Unit) Table 27. Global Targeted Protein Degradation (TPD) Therapy Drugs Sale by Application (2021-2026) & (K Units) Table 28. Global Targeted Protein Degradation (TPD) Therapy Drugs Sale Market Share by Application (2021-2026) Table 29. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Application (2021-2026) & ($ million) Table 30. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Application (2021-2026) Table 31. Global Targeted Protein Degradation (TPD) Therapy Drugs Sale Price by Application (2021-2026) & (US$/Unit) Table 32. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales by Company (2021-2026) & (K Units) Table 33. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Company (2021-2026) Table 34. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Company (2021-2026) & ($ millions) Table 35. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Company (2021-2026) Table 36. Global Targeted Protein Degradation (TPD) Therapy Drugs Sale Price by Company (2021-2026) & (US$/Unit) Table 37. Key Manufacturers Targeted Protein Degradation (TPD) Therapy Drugs Producing Area Distribution and Sales Area Table 38. Players Targeted Protein Degradation (TPD) Therapy Drugs Products Offered Table 39. Targeted Protein Degradation (TPD) Therapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) Table 40. New Products and Potential Entrants Table 41. Market M&A Activity & Strategy Table 42. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales by Geographic Region (2021-2026) & (K Units) Table 43. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share Geographic Region (2021-2026) Table 44. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Geographic Region (2021-2026) & ($ millions) Table 45. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Geographic Region (2021-2026) Table 46. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales by Country/Region (2021-2026) & (K Units) Table 47. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Country/Region (2021-2026) Table 48. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Country/Region (2021-2026) & ($ millions) Table 49. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Country/Region (2021-2026) Table 50. Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales by Country (2021-2026) & (K Units) Table 51. Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Country (2021-2026) Table 52. Americas Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Country (2021-2026) & ($ millions) Table 53. Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales by Type (2021-2026) & (K Units) Table 54. Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales by Application (2021-2026) & (K Units) Table 55. APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales by Region (2021-2026) & (K Units) Table 56. APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Region (2021-2026) Table 57. APAC Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Region (2021-2026) & ($ millions) Table 58. APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales by Type (2021-2026) & (K Units) Table 59. APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales by Application (2021-2026) & (K Units) Table 60. Europe Targeted Protein Degradation (TPD) Therapy Drugs Sales by Country (2021-2026) & (K Units) Table 61. Europe Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Country (2021-2026) & ($ millions) Table 62. Europe Targeted Protein Degradation (TPD) Therapy Drugs Sales by Type (2021-2026) & (K Units) Table 63. Europe Targeted Protein Degradation (TPD) Therapy Drugs Sales by Application (2021-2026) & (K Units) Table 64. Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Sales by Country (2021-2026) & (K Units) Table 65. Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Country (2021-2026) Table 66. Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Sales by Type (2021-2026) & (K Units) Table 67. Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Sales by Application (2021-2026) & (K Units) Table 68. Key Market Drivers & Growth Opportunities of Targeted Protein Degradation (TPD) Therapy Drugs Table 69. Key Market Challenges & Risks of Targeted Protein Degradation (TPD) Therapy Drugs Table 70. Key Industry Trends of Targeted Protein Degradation (TPD) Therapy Drugs Table 71. Targeted Protein Degradation (TPD) Therapy Drugs Raw Material Table 72. Key Suppliers of Raw Materials Table 73. Targeted Protein Degradation (TPD) Therapy Drugs Distributors List Table 74. Targeted Protein Degradation (TPD) Therapy Drugs Customer List Table 75. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Forecast by Region (2027-2032) & (K Units) Table 76. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Forecast by Region (2027-2032) & ($ millions) Table 77. Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 78. Americas Targeted Protein Degradation (TPD) Therapy Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions) Table 79. APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales Forecast by Region (2027-2032) & (K Units) Table 80. APAC Targeted Protein Degradation (TPD) Therapy Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions) Table 81. Europe Targeted Protein Degradation (TPD) Therapy Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 82. Europe Targeted Protein Degradation (TPD) Therapy Drugs Revenue Forecast by Country (2027-2032) & ($ millions) Table 83. Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 84. Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Revenue Forecast by Country (2027-2032) & ($ millions) Table 85. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Forecast by Type (2027-2032) & (K Units) Table 86. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Forecast by Type (2027-2032) & ($ millions) Table 87. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Forecast by Application (2027-2032) & (K Units) Table 88. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Forecast by Application (2027-2032) & ($ millions) Table 89. BMS Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 90. BMS Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 91. BMS Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. BMS Main Business Table 93. BMS Latest Developments Table 94. Arvinas Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 95. Arvinas Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 96. Arvinas Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Arvinas Main Business Table 98. Arvinas Latest Developments Table 99. Kymera Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 100. Kymera Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 101. Kymera Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Kymera Main Business Table 103. Kymera Latest Developments Table 104. Nurix Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 105. Nurix Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 106. Nurix Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Nurix Main Business Table 108. Nurix Latest Developments Table 109. C4 Therapeutics Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 110. C4 Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 111. C4 Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. C4 Therapeutics Main Business Table 113. C4 Therapeutics Latest Developments Table 114. Cullgen Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 115. Cullgen Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 116. Cullgen Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Cullgen Main Business Table 118. Cullgen Latest Developments Table 119. Kintor Pharma Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 120. Kintor Pharma Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 121. Kintor Pharma Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Kintor Pharma Main Business Table 123. Kintor Pharma Latest Developments Table 124. Prelude Therapeutics Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 125. Prelude Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 126. Prelude Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Prelude Therapeutics Main Business Table 128. Prelude Therapeutics Latest Developments Table 129. AbbVie Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 130. AbbVie Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 131. AbbVie Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. AbbVie Main Business Table 133. AbbVie Latest Developments Table 134. Accutar Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 135. Accutar Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 136. Accutar Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Accutar Main Business Table 138. Accutar Latest Developments Table 139. AnHorn Medicines Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 140. AnHorn Medicines Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 141. AnHorn Medicines Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. AnHorn Medicines Main Business Table 143. AnHorn Medicines Latest Developments Table 144. Astellas Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 145. Astellas Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 146. Astellas Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Astellas Main Business Table 148. Astellas Latest Developments Table 149. Auron Therapeutics Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 150. Auron Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 151. Auron Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Auron Therapeutics Main Business Table 153. Auron Therapeutics Latest Developments Table 154. Axter Therapeutics Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 155. Axter Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 156. Axter Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Axter Therapeutics Main Business Table 158. Axter Therapeutics Latest Developments Table 159. Biotheryx Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 160. Biotheryx Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 161. Biotheryx Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Biotheryx Main Business Table 163. Biotheryx Latest Developments Table 164. Dialectic Therapeutics Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 165. Dialectic Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 166. Dialectic Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Dialectic Therapeutics Main Business Table 168. Dialectic Therapeutics Latest Developments Table 169. Hinova Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 170. Hinova Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 171. Hinova Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 172. Hinova Main Business Table 173. Hinova Latest Developments Table 174. Hinova Pharmaceuticals Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 175. Hinova Pharmaceuticals Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 176. Hinova Pharmaceuticals Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 177. Hinova Pharmaceuticals Main Business Table 178. Hinova Pharmaceuticals Latest Developments Table 179. Haisco Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 180. Haisco Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 181. Haisco Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 182. Haisco Main Business Table 183. Haisco Latest Developments Table 184. Leadingtac Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 185. Leadingtac Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 186. Leadingtac Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 187. Leadingtac Main Business Table 188. Leadingtac Latest Developments Table 189. Mitsubishi Tanabe Pharma America Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 190. Mitsubishi Tanabe Pharma America Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 191. Mitsubishi Tanabe Pharma America Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 192. Mitsubishi Tanabe Pharma America Main Business Table 193. Mitsubishi Tanabe Pharma America Latest Developments Table 194. NiKang Therapeutics Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 195. NiKang Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 196. NiKang Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 197. NiKang Therapeutics Main Business Table 198. NiKang Therapeutics Latest Developments Table 199. Ubix Therapeutics Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 200. Ubix Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 201. Ubix Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 202. Ubix Therapeutics Main Business Table 203. Ubix Therapeutics Latest Developments Table 204. Foghorn Therapeutics Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 205. Foghorn Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 206. Foghorn Therapeutics Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 207. Foghorn Therapeutics Main Business Table 208. Foghorn Therapeutics Latest Developments Table 209. Beigene, Ltd. Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 210. Beigene, Ltd. Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 211. Beigene, Ltd. Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 212. Beigene, Ltd. Main Business Table 213. Beigene, Ltd. Latest Developments Table 214. Jiangsu Hengrui Medicine Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 215. Jiangsu Hengrui Medicine Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 216. Jiangsu Hengrui Medicine Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 217. Jiangsu Hengrui Medicine Main Business Table 218. Jiangsu Hengrui Medicine Latest Developments Table 219. Qilu Pharmaceutical Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 220. Qilu Pharmaceutical Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 221. Qilu Pharmaceutical Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 222. Qilu Pharmaceutical Main Business Table 223. Qilu Pharmaceutical Latest Developments Table 224. Simcere Pharma Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 225. Simcere Pharma Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 226. Simcere Pharma Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 227. Simcere Pharma Main Business Table 228. Simcere Pharma Latest Developments Table 229. Chia Tai Tianqing Pharmaceutical Basic Information, Targeted Protein Degradation (TPD) Therapy Drugs Manufacturing Base, Sales Area and Its Competitors Table 230. Chia Tai Tianqing Pharmaceutical Targeted Protein Degradation (TPD) Therapy Drugs Product Portfolios and Specifications Table 231. Chia Tai Tianqing Pharmaceutical Targeted Protein Degradation (TPD) Therapy Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 232. Chia Tai Tianqing Pharmaceutical Main Business Table 233. Chia Tai Tianqing Pharmaceutical Latest Developments List of Figures Figure 1. Picture of Targeted Protein Degradation (TPD) Therapy Drugs Figure 2. Targeted Protein Degradation (TPD) Therapy Drugs Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Growth Rate 2021-2032 (K Units) Figure 7. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth Rate 2021-2032 ($ millions) Figure 8. Targeted Protein Degradation (TPD) Therapy Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions) Figure 9. Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Country/Region (2025) Figure 10. Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Country/Region (2021, 2025 & 2032) Figure 11. Product Picture of PROTAC Figure 12. Product Picture of Molecular Glues Figure 13. Product Picture of Others Figure 14. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Type in 2026 Figure 15. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Type (2021-2026) Figure 16. Product Picture of Degradation of Transcription Factors Type Figure 17. Product Picture of Degradation of Scaffold Proteins Type Figure 18. Product Picture of Others Figure 19. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Target Protein in 2026 Figure 20. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Target Protein (2021-2026) Figure 21. Product Picture of Oral Drugs Figure 22. Product Picture of Injectable Drugs Figure 23. Product Picture of Others Figure 24. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Administration Route in 2026 Figure 25. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Administration Route (2021-2026) Figure 26. Targeted Protein Degradation (TPD) Therapy Drugs Consumed in Cancer Figure 27. Global Targeted Protein Degradation (TPD) Therapy Drugs Market: Cancer (2021-2026) & (K Units) Figure 28. Targeted Protein Degradation (TPD) Therapy Drugs Consumed in Immune Diseases Figure 29. Global Targeted Protein Degradation (TPD) Therapy Drugs Market: Immune Diseases (2021-2026) & (K Units) Figure 30. Targeted Protein Degradation (TPD) Therapy Drugs Consumed in Others Figure 31. Global Targeted Protein Degradation (TPD) Therapy Drugs Market: Others (2021-2026) & (K Units) Figure 32. Global Targeted Protein Degradation (TPD) Therapy Drugs Sale Market Share by Application (2025) Figure 33. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Application in 2026 Figure 34. Targeted Protein Degradation (TPD) Therapy Drugs Sales by Company in 2026 (K Units) Figure 35. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Company in 2026 Figure 36. Targeted Protein Degradation (TPD) Therapy Drugs Revenue by Company in 2026 ($ millions) Figure 37. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Company in 2026 Figure 38. Global Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Geographic Region (2021-2026) Figure 39. Global Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Geographic Region in 2026 Figure 40. Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales 2021-2026 (K Units) Figure 41. Americas Targeted Protein Degradation (TPD) Therapy Drugs Revenue 2021-2026 ($ millions) Figure 42. APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales 2021-2026 (K Units) Figure 43. APAC Targeted Protein Degradation (TPD) Therapy Drugs Revenue 2021-2026 ($ millions) Figure 44. Europe Targeted Protein Degradation (TPD) Therapy Drugs Sales 2021-2026 (K Units) Figure 45. Europe Targeted Protein Degradation (TPD) Therapy Drugs Revenue 2021-2026 ($ millions) Figure 46. Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Sales 2021-2026 (K Units) Figure 47. Middle East & Africa Targeted Protein Degradation (TPD) Therapy Drugs Revenue 2021-2026 ($ millions) Figure 48. Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Country in 2026 Figure 49. Americas Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Country (2021-2026) Figure 50. Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Type (2021-2026) Figure 51. Americas Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Application (2021-2026) Figure 52. United States Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 53. Canada Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 54. Mexico Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 55. Brazil Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 56. APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Region in 2026 Figure 57. APAC Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Region (2021-2026) Figure 58. APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Type (2021-2026) Figure 59. APAC Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Application (2021-2026) Figure 60. China Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 61. Japan Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 62. South Korea Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 63. Southeast Asia Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 64. India Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 65. Australia Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 66. China Taiwan Targeted Protein Degradation (TPD) Therapy Drugs Revenue Growth 2021-2026 ($ millions) Figure 67. Europe Targeted Protein Degradation (TPD) Therapy Drugs Sales Market Share by Country in 2026 Figure 68. Europe Targeted Protein Degradation (TPD) Therapy Drugs Revenue Market Share by Country (2021-2026)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
LP Information社の 医薬品・ヘルスケア分野 での最新刊レポート
本レポートと同じKEY WORD（protein）の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
